Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Potential new gastric prokinetic agent related to human motilin

May 16, 2000

AU-461 headed for development as a novel therapeutic agent for peptic ulcer

May 15, 2000

Hepatitis C combination therapy launched in Spain

May 12, 2000

New agents for HCV infections under study at AxyS

May 12, 2000

Novirio receives NIAID grant to further R&D of anti-HBV drugs

May 12, 2000

Anti-HCV ribozyme well tolerated in volunteers; studies in chronically infected patients begin

May 12, 2000

New drug for hepatitis B and C discovered in China

May 12, 2000

Novavax enters licensing option for metronidazole analogues

May 11, 2000

Novirio's new anti-HBV nucleosides among Antiviral Research conference highlights

May 9, 2000

Addition of thymosin alpha 1 to interferon therapy may improve outcome in chronic HCV

May 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...